These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 19734325)
21. YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9. Liu YN; Pan SL; Peng CY; Guh JH; Huang DM; Chang YL; Lin CH; Pai HC; Kuo SC; Lee FY; Teng CM J Pharmacol Exp Ther; 2006 Jan; 316(1):35-41. PubMed ID: 16183705 [TBL] [Abstract][Full Text] [Related]
22. Intermittent short-duration exposure to low wall shear stress induces intimal thickening in arteries exposed to chronic high shear stress. Nanjo H; Sho E; Komatsu M; Sho M; Zarins CK; Masuda H Exp Mol Pathol; 2006 Feb; 80(1):38-45. PubMed ID: 15961075 [TBL] [Abstract][Full Text] [Related]
23. [Effects of tissue inhibitor of matrix metalloproteinases-4 on the activities of matrix metalloproteinases and collagen of artery: experiment with rats]. Zu LY; Guo YH; Chen L; Li Q; Yan H; Gao W Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(7):472-5. PubMed ID: 16677575 [TBL] [Abstract][Full Text] [Related]
24. Marimastat inhibits neointimal thickening in a model of human arterial intimal hyperplasia. Peterson M; Porter KE; Loftus IM; Thompson MM; London NJ Eur J Vasc Endovasc Surg; 2000 May; 19(5):461-7. PubMed ID: 10828225 [TBL] [Abstract][Full Text] [Related]
25. The endothelin axis and gelatinase activity in alveolar macrophages after brain-stem death injury: a pilot study. Sutherland AJ; Ware RS; Winterford C; Fraser JF J Heart Lung Transplant; 2007 Oct; 26(10):1040-7. PubMed ID: 17919625 [TBL] [Abstract][Full Text] [Related]
26. A comparison of six statins on the development of intimal hyperplasia in a human vein culture model. Corpataux JM; Naik J; Porter KE; London NJ Eur J Vasc Endovasc Surg; 2005 Feb; 29(2):177-81. PubMed ID: 15649726 [TBL] [Abstract][Full Text] [Related]
27. MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation. Dwivedi A; Slater SC; George SJ Cardiovasc Res; 2009 Jan; 81(1):178-86. PubMed ID: 18852254 [TBL] [Abstract][Full Text] [Related]
28. Experimental hindlimb ischemia leads to neutrophil-mediated increases in gastrocnemius MMP-2 and -9 activity: a potential mechanism for ischemia induced MMP activation. Muhs BE; Gagne P; Plitas G; Shaw JP; Shamamian P J Surg Res; 2004 Apr; 117(2):249-54. PubMed ID: 15047130 [TBL] [Abstract][Full Text] [Related]
29. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation. Stack MS; Itoh Y; Young TN; Nagase H Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767 [TBL] [Abstract][Full Text] [Related]
30. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005 [TBL] [Abstract][Full Text] [Related]
31. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Jeyabalan A; Novak J; Danielson LA; Kerchner LJ; Opett SL; Conrad KP Circ Res; 2003 Dec; 93(12):1249-57. PubMed ID: 14593002 [TBL] [Abstract][Full Text] [Related]
32. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Godin D; Ivan E; Johnson C; Magid R; Galis ZS Circulation; 2000 Dec; 102(23):2861-6. PubMed ID: 11104745 [TBL] [Abstract][Full Text] [Related]
33. Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Galis ZS; Johnson C; Godin D; Magid R; Shipley JM; Senior RM; Ivan E Circ Res; 2002 Nov; 91(9):852-9. PubMed ID: 12411401 [TBL] [Abstract][Full Text] [Related]
34. ET(A)/ET(B) receptor antagonist bosentan inhibits neointimal development in collared carotid arteries of rabbits. Marano G; Palazzesi S; Bernucci P; Grigioni M; Formigari R; Ballerini L Life Sci; 1998; 63(18):PL259-66. PubMed ID: 9806221 [TBL] [Abstract][Full Text] [Related]
35. Expression of MMP, HPSE, and FAP in stroma promoted corneal neovascularization induced by different etiological factors. Shi W; Liu J; Li M; Gao H; Wang T Curr Eye Res; 2010 Nov; 35(11):967-77. PubMed ID: 20958185 [TBL] [Abstract][Full Text] [Related]
36. Flow regulation of 72-kD collagenase IV (MMP-2) after experimental arterial injury. Bassiouny HS; Song RH; Hong XF; Singh A; Kocharyan H; Glagov S Circulation; 1998 Jul; 98(2):157-63. PubMed ID: 9679722 [TBL] [Abstract][Full Text] [Related]
37. Effects of long-term treatment with nonselective endothelin receptor antagonist, TAK-044, on remodeling of cardiovascular system with sustained volume overload. Tojo T; Tsunoda Y; Nakada S; Tomoike H J Cardiovasc Pharmacol; 2000 May; 35(5):777-85. PubMed ID: 10813381 [TBL] [Abstract][Full Text] [Related]
38. Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure. Anacak GY; Ustünes L; Dilsiz OY; Ergul A Vascul Pharmacol; 2010; 53(5-6):193-9. PubMed ID: 20709189 [TBL] [Abstract][Full Text] [Related]
39. Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo. Chesler NC; Ku DN; Galis ZS Am J Physiol; 1999 Nov; 277(5):H2002-9. PubMed ID: 10564157 [TBL] [Abstract][Full Text] [Related]
40. Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide. Kuhnast B; Bodenstein C; Haubner R; Wester HJ; Senekowitsch-Schmidtke R; Schwaiger M; Weber WA Nucl Med Biol; 2004 Apr; 31(3):337-44. PubMed ID: 15028246 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]